RxDoctor Payments Data

Mahesh Parameswaran, MD

Otolaryngology · Leesburg, VANPI 1699753442

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,850 of the $3,918 with a category attached, or 72.7%. 17 manufacturers reported payments, led by Medtronic at 49.3% of the total. Reporting peaked in 2023 at $2,309 and has fallen 81.7% since, to $422 in 2025.

$3,918in general payments, 2019–2025

Across 100 payments — averaging $39.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Regeneron Healthcare Solutions, Inc.$394
  • Acclarent, Inc$370
  • Optinose US, Inc.$239
  • AstraZeneca$229
  • Neurent Medical Limited$188
  • plus $564 from 11 others

What the payments were for

  • Travel & lodging$1,06827%
  • Food & beverage$2,85073%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,918 in reported general payments places this provider in the 80th percentile of 241 otolaryngology providers in Virginia.

See all otolaryngology providers in Virginia

Medicare billing

Part B allowed, 2024
$76,152
Medicare patients
221
Services billed
474

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Budesonide16$1,839
Ipratropium Bromide55$1,419
Azelastine Hcl14$537
Pantoprazole Sodium32$487
Cefdinir15$297
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$164
Montelukast Sodium12$161
Methylprednisolone14$86

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Leesburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →